• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST PAUL DELTEC POWER PORT-A-CATH; PORT AND CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST PAUL DELTEC POWER PORT-A-CATH; PORT AND CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAV Back to Search Results
Model Number 21-4455-24
Medical Device Problem Codes Fluid/Blood Leak (1250); Fracture (1260)
Health Effect - Clinical Code Extravasation (1842)
Date of Event 07/14/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.Device manufacture date is unknown, no product information has been provided.
 
Event or Problem Description
It was reported that the device was explanted on (b)(6) 2022 and was noted to have a fracture in the body of the device, allowing extravasation of infused fluids.Unknown if there was patient injury.The patient received chemotherapy through port prior to awareness that there was a defect.The device was removed and replaced.Additional information was requested; however, no further information was received.
 
Additional Manufacturer Narrative
H10: a device history record (dhr) review was conducted which indicated all inspections were completed and no issues were noted during manufacture.A product sample was received for evaluation.Visual inspection under normal conditions of illumination.The sample was received with the catheter separate to the port, a small section still attached to the inlet tube of the port; the surface on both catheter sections looks smooth there are no marks of stress.Failure mode reported is not confirmed.Other analysis was not required.Device passed all functional testing.No problem found.After a review of the different verifications that are performed during the manufacturing process to detect damage components and a 100% test for occlusion or leaks leak test, the most probable root cause is that damaged occurred after the product left the facility.This issue will be monitored for any increase in occurrence.If the occurrence of this issue increases significantly, additional investigative action will be taken accordingly.This remediation mdr was generated under protocol (b)(4), as a result of warning letter cms# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DELTEC POWER PORT-A-CATH
Common Device Name
PORT AND CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAV
Manufacturer (Section D)
ST PAUL
1265 grey fox rd.
st. paul MN 55112
Manufacturer (Section G)
NULL
1265 grey fox rd.
st. paul MN 55112
Manufacturer Contact
jim vegel
6000 nathan lane north
minneapolis, MN 55442
MDR Report Key15249680
Report Number3012307300-2022-15579
Device Sequence Number6493456
Product Code LJT
UDI-Device Identifier10610586032707
UDI-Public10610586032707
Combination Product (Y/N)N
Initial Reporter StateNC
Initial Reporter CountryUS
PMA/510(K) Number
K072657
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 04/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number21-4455-24
Device Catalogue Number21-4455-24
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/19/2022
Supplement Date Received by Manufacturer02/03/2023
Initial Report FDA Received Date08/18/2022
Supplement Report FDA Received Date04/05/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age78 YR
Patient SexFemale
Patient Weight31 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-